Genmab A/S (VIE:GMAB)
246.80
-1.20 (-0.48%)
At close: Sep 26, 2025
Genmab Market Cap
Genmab has a market cap or net worth of €15.18 billion as of September 29, 2025. Its market cap has decreased by -3.73% in one year.
Market Cap
15.18B
Enterprise Value
12.84B
Revenue
3.11B
Ranking
n/a
PE Ratio
13.01
Stock Price
€246.80
Market Cap Chart
Since October 18, 2000, Genmab's market cap has increased from 485.53M to 15.18B, an increase of 3,027.24%. That is a compound annual growth rate of 14.79%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 26, 2025 | 15.18B | 19.40% |
Dec 30, 2024 | 12.72B | -32.67% |
Dec 29, 2023 | 18.89B | -26.92% |
Dec 30, 2022 | 25.84B | 11.67% |
Dec 30, 2021 | 23.14B | 6.90% |
Dec 30, 2020 | 21.65B | 67.74% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Erste Group Bank AG | 33.09B |
VERBUND AG | 21.12B |
OMV Aktiengesellschaft | 15.19B |
Raiffeisen Bank International AG | 9.68B |
Strabag SE | 8.97B |
BAWAG Group AG | 8.62B |
Telekom Austria AG | 6.20B |
Vienna Insurance Group AG | 5.94B |